Nascent Biotech Inc. financial data

Location
North Palm Beach, FL
Fiscal year end
31 March
Latest financial report
10-Q - Q2 2024 - 14 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 76.7 % +160%
Debt-to-equity -430 % -200%
Return On Equity 1.03K % +526%
Return On Assets -313 % +19.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 172M shares +21.8%
Common Stock, Shares, Outstanding 172M shares +19.9%
Entity Public Float 19.2M USD 0%
Common Stock, Value, Issued 172K USD +19.9%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 100K USD -58.2%
General and Administrative Expense 422K USD +10.1%
Operating Income (Loss) -2.09M USD -2.22%
Net Income (Loss) Attributable to Parent -1.92M USD +5.71%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 227K USD +188%
Assets 227K USD +188%
Liabilities, Current 742K USD -39.9%
Liabilities 742K USD -39.9%
Retained Earnings (Accumulated Deficit) -24.6M USD -11.2%
Stockholders' Equity Attributable to Parent -515K USD +53.9%
Liabilities and Equity 227K USD +188%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -325K USD -99.6%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 172M shares +19.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 47.4K USD +400%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 1.24M USD -29.5%
Deferred Tax Assets, Operating Loss Carryforwards 1.24M USD -29.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 24M USD +14.8%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 149K USD -91.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%